Life expectancy following a cardiovascular event in individuals with and without type 2 diabetes: A UK multi-ethnic population-based observational study
- PMID: 37169664
- DOI: 10.1016/j.numecd.2023.04.003
Life expectancy following a cardiovascular event in individuals with and without type 2 diabetes: A UK multi-ethnic population-based observational study
Abstract
Background and aims: We aimed to evaluate the life expectancy following the first cardiovascular disease (CVD) event by type 2 diabetes (T2D) status and ethnicity.
Methods and results: We used the Clinical Practice Research Datalink database in England (UK), linked to the Hospital Episode Statistics information, to identify individuals with and without T2D who survived a first CVD event between 1st Jan 2007 and 31st Dec 2017; subsequent death events were extracted from the Office for National Statistics database. Ethnicity was categorised as White, South Asian (SA), Black, or other. Flexible parametric survival models were used to estimate survival and predict life expectancy. 59,939 individuals with first CVD event were included: 7596 (12.7%) with T2D (60.9% men; mean age at event: 69.7 years [63.2 years in SA, 65.9 in Black, 70.2 in White]) and 52,343 without T2D (56.7% men; 65.9 years [54.7 in Black, 58.2 in SA, 66.3 in White]). Accounting for potential confounders (sex, deprivation, lipid-lowering medication, current smoking, and pre-existing hypertension), comparing individuals with vs without T2D the mortality rate was 53% higher in White (hazard ratio [HR]: 1.53 [95% CI: 1.44, 1.62]), corresponding to a potential loss of 3.87 (3.30, 4.44) life years at the age of 50 years in individuals with T2D. No evidence of a difference in life expectancy was observed in individuals of SA (HR: 0.82 [0.52, 1.29]; -1.36 [-4.58, 1.86] life years), Black (HR: 1.26 [0.59, 2.70]; 1.21 [-2.99, 5.41] life years); and other (HR: 1.64 [0.80, 3.39]; 3.89 [-2.28, 9.99] life years) ethnic group.
Conclusion: Following a CVD event, T2D is associated with a different prognosis and life years lost among ethnic groups.
Keywords: Cardiovascular disease; Diabetes; Life expectancy; Prognosis; Years of life lost.
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest Professor Khunti is the National Lead for multiple long-term conditions for National Institute for Health Research Applied Research Collaboration (NIHR ARC). Professor Khunti has acted as a consultant, speaker or received grants for investigator-initiated studies for Astra Zeneca, Abbott, Amgen, Bayer, Novartis, Novo Nordisk, Roche, Servier, Sanofi-Aventis, Lilly and Merck Sharp & Dohme, Boehringer Ingelheim, Oramed Pharmaceuticals and Applied Therapeutics. Dr Zaccardi is a speaker fees from Napp Pharmaceuticals and Boehringer Ingelheim. Professor Davies has acted as a consultant, advisory board member and speaker for Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Boehringer Ingelheim, AstraZeneca and Janssen, an advisory board member for Servier and Gilead Sciences Ltd and as a speaker for Napp Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation and Takeda Pharmaceuticals International Inc. Professor Davies has received grants in support of investigator and investigator-initiated trials from Novo Nordisk, Sanofi-Aventis, Lilly, Boehringer Ingelheim, AstraZeneca and Janssen. All other authors have no conflict of interest.
Similar articles
-
Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi-ethnic population.J Diabetes Investig. 2021 Jul;12(7):1175-1182. doi: 10.1111/jdi.13464. Epub 2020 Dec 15. J Diabetes Investig. 2021. PMID: 33206469 Free PMC article.
-
Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic Subgroups.Diabetes Care. 2017 Mar;40(3):338-345. doi: 10.2337/dc16-1616. Epub 2016 Dec 20. Diabetes Care. 2017. PMID: 27998911
-
Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.PLoS Med. 2019 Oct 7;16(10):e1002942. doi: 10.1371/journal.pmed.1002942. eCollection 2019 Oct. PLoS Med. 2019. PMID: 31589609 Free PMC article.
-
Comparison of mortality in people with type 2 diabetes between different ethnic groups: Systematic review and meta-analysis of longitudinal studies.PLoS One. 2025 Jan 17;20(1):e0314318. doi: 10.1371/journal.pone.0314318. eCollection 2025. PLoS One. 2025. PMID: 39823451 Free PMC article.
-
Differential manifestation of type 2 diabetes in Black Africans and White Europeans with recently diagnosed type 2 diabetes: A systematic review.Diabetes Metab Syndr. 2024 Aug;18(8):103115. doi: 10.1016/j.dsx.2024.103115. Epub 2024 Sep 4. Diabetes Metab Syndr. 2024. PMID: 39244907
Cited by
-
Association between within-target risk factors and life expectancy free from cardiovascular disease, cancer, and dementia in individuals with type 2 diabetes in New Zealand between 1994 and 2018: a multi-ethnic cohort study.BMC Med. 2024 Nov 11;22(1):527. doi: 10.1186/s12916-024-03743-y. BMC Med. 2024. PMID: 39523328 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials